Sexual health campaigners are warning a newly launched trial in the UK will fail if not enough people of color take part.
The new Impact study is now live, after a delayed start due to some computer problems.
The three-year trial will see 10,000 people using the Pre-Exposure Prophylaxis (PrEP) drug Truvada.
Marc Thompson runs Prepster, the PrEP advocacy group. He tells GSN, ‘If enough black men don’t take part, the trial won’t have been as successful as we hoped. It will create a health inequality.’